Evidence map›Paper›PMID 25150094›Full record

ArticleJournal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology2014

Regadenoson-induced bradycardia and hypotension: possible mechanism and antidote.

S R Underwood, K A Latus, E Reyes, K Standbridge, S Walker, K Wechalekar

Abstract readLetter
PubMed Publisher
In one paragraph

Article in Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Incidence of atrioventricular block with vasodilator stress SPECT: A meta-analysis.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2019
    Pooled it
  2. Safety and tolerability of pharmacologic stress with the selective AClinical research in cardiology : official journal of the German Cardiac Society · 2026
    Article
  3. Article
  4. Asystole following Regadenoson administration: Review of literature, risk factors and management.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2021
    Review
  5. Article
  6. Adverse effects associated with regadenoson myocardial perfusion imaging.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2018
    Article
  7. Regadenoson in Myocardial Perfusion Study - First Institutional Experiences in Bosnia and Herzegovina.Acta informatica medica : AIM : journal of the Society for Medical Informatics of Bosnia & Herzegovina : casopis Drustva za medicinsku informatiku BiH · 2016
    Article
  8. Serious and potentially life threatening complications of cardiac stress testing: Physiological mechanisms and management strategies.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2015
    Review
  9. Serious complications associated with regadenoson administration for myocardial perfusion imaging: a commentary.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2014
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

S R UnderwoodImperial College London, London, United Kingdom, srunderwood@imperial.ac.uk.
K A Latus
E Reyes
K Standbridge
S Walker
K Wechalekar

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Adenosine A2 Receptor AgonistsAntidotesAtropineBradycardiaExercise TestHumansHypotensionPurinesPyrazolesVasodilator AgentsAdenosine A2 Receptor AgonistsAntidotesAtropinePurinesPyrazolesregadenosonVasodilator Agents

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.